CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and ...

EDEN (short for environmentally-derived evolutionary network) processes evolutionary DNA from more than one million newly discovered species, collected over five years at 150 locations in 28 countries ...

The AISRF is the Australian Government's largest bilateral program dedicated to science. It has supported over 370 collaborative activities since ...

Key market opportunities lie in AAV gene therapy advancements for hereditary retinal diseases. Future prospects include combination with CRISPR for precise genome editing, novel delivery platforms, ...

IT and Industries Minister D. Sridhar Babu, on Wednesday, said that BioAsia 2026 surpassed expectations, helped amplify Telangana’s progress and aspirations on the Life Sciences front and maintained ...

Home > Pressemitteilung: 1.25 million euros for research into ...

Researchers have demonstrated that lipid nanoparticles can package and deliver an entire therapeutic gene along with ...

Agentic AI leads the artificial intelligence field. Machine voice is set to be the next innovation. Audio models will reduce ...

Researchers at Dallas-based Colossal Biosciences rely on ancient DNA from extinct species and the genome of their closest living relatives to determine how they can be brought back. Why it matters: ...

Fast functional testing of genetic variants, from newborn genomes to disease models like zebrafish, is transforming ambiguous DNA findings into confident, real‑time treatment decisions.

India, Feb. 19 -- The Artificial Intelligence landscape is rapidly evolving with Agentic AI as the latest frontier and ...

Ben Lamm, the CEO and co-founder of the technology firm Colossal Biosciences, does not want to play favorites with the company’s various de-extinction projects. One look around a newly finished ...